Kunthel By

发表

Estimating Equations Approaches to Nuisance Parameters and Outcome-Dependent Sampling Problems for Marginal Regression Models and Generalized Linear Mixed Models When Outcomes Are Correlated

Kunthel By, 2011 .

FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia

K. Goldberg, R. Pazdur, A. Farrell, 2019, Clinical Cancer Research.

Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.

J. Burke, I. Flinn, A. Idoine, 2022, The Lancet. Haematology.

Role of allostatic load in sociodemographic patterns of pain prevalence in the U.S. population.

G. Slade, A. Sanders, Kunthel By, 2012, The journal of pain : official journal of the American Pain Society.

Entacapone and prostate cancer in Parkinson's disease patients: A large Veterans Affairs healthcare system study.

F. Cunningham, K. Hur, Stephine Keeton, 2018, Parkinsonism & related disorders.

Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study

Kunthel By, Mark Levenson, Chris Worrall, 2014, Pharmacoepidemiology and drug safety.

ORTH: R and SAS software for regression models of correlated binary data based on orthogonalized residuals and alternating logistic regressions

John S. Preisser, Bahjat F. Qaqish, Jamie Perin, 2014, Comput. Methods Programs Biomed..

Deletion diagnostics for alternating logistic regressions

B. Qaqish, J. Preisser, J. Perin, 2012, Biometrical journal. Biometrische Zeitschrift.

Performance of One-Step Approximation Relative to Exact Cluster Cook's Distance for GEE

B. Qaqish, J. Preisser, Kunthel By, 2008 .

Excess risk of temporomandibular disorder associated with cigarette smoking in young adults.

W. Maixner, L. Diatchenko, G. Slade, 2012, The journal of pain : official journal of the American Pain Society.

Important statistical considerations in the evaluation of post‐market studies to assess whether opioids with abuse‐deterrent properties result in reduced abuse in the community

Mark S Levenson, Stephine Keeton, C. Hwang, 2018, Pharmacoepidemiology and drug safety.

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia

S. Opat, C. Tam, A. Tedeschi, 2023, HemaSphere.

Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study.

Eric Bair, Kunthel By, William Maixner, 2011, The journal of pain : official journal of the American Pain Society.

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens

R. Pazdur, R. Sridhara, A. Farrell, 2019, Blood.

Analysis of early mortality in randomized clinical trials evaluating anti-PD-1/PD-L1 antibodies: A systematic analysis by the United States Food and Drug Administration (FDA).

R. Pazdur, R. Sridhara, M. Theoret, 2019, Journal of Clinical Oncology.

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia

W. Novotny, S. Opat, C. Tam, 2023, Blood Advances.

Phase 2 Study of Zanubrutinib in BTK Inhibitor-Intolerant Patients (Pts) with Relapsed/Refractory B-Cell Malignancies

J. Burke, I. Flinn, T. Guthrie, 2021, Blood.

Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies

I. Flinn, A. Idoine, M. Shadman, 2022, Blood.

Role of allostatic load in sociodemographic patterns of pain prevalence in the U.S. population.

G. Slade, A. Sanders, Kunthel By, 2012, The journal of pain : official journal of the American Pain Society.